Q: hi folks, thoughts on Q1 results for Anaergia, anrg/t....would you view company as Speculative, or think they have overcome past problems, and things look good from here....Buy or Hold, thanks, jb
5i Research Answer:
Loss of 1c per share beat estimates of -1.9c; revenue of $55.2M beat estimates of $38.9M. EBITDA was positive $1.1M, ahead of estimates of negative $0.4M. Revenue rose 122%. EBITDA was 127% better. Gross margins increased 1.3 points. It was the third good quarter. Backlog is now $265M, up 32% year over year. This was a solid quarter, but of course the stock ran up over the past year. We would certainly still consider it speculative, but many of the prior issues appear to have been fixed.